Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

726 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No observed bidirectional effect between tenofovir diphosphate concentrations and gender-affirming hormone concentrations among transgender persons switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for HIV pre-exposure prophylaxis.
Patel N, Morris S, Burke L, Chow K, Pacheco D, Anderson P, Stancyzk F, Blumenthal J. Patel N, et al. Among authors: blumenthal j. Br J Clin Pharmacol. 2024 Apr 22. doi: 10.1111/bcp.16071. Online ahead of print. Br J Clin Pharmacol. 2024. PMID: 38646796
Predictors of Long-Term HIV Pre-exposure Prophylaxis Adherence After Study Participation in Men Who Have Sex With Men.
Hoenigl M, Hassan A, Moore DJ, Anderson PL, Corado K, Dubé MP, Ellorin EE, Blumenthal J, Morris SR; California Collaborative Treatment Group (CCTG) 601 Team. Hoenigl M, et al. Among authors: blumenthal j. J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):166-174. doi: 10.1097/QAI.0000000000002003. J Acquir Immune Defic Syndr. 2019. PMID: 30865175 Free PMC article. Clinical Trial.
Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study.
Morris SR, Jain S, Blumenthal J, Bolan R, Dubé MP, Henderson P, Corado K, Sun S, He F, Chow K, Burke L, Anderson PL, Moore DJ. Morris SR, et al. Among authors: blumenthal j. J Acquir Immune Defic Syndr. 2022 Dec 15;91(5):453-459. doi: 10.1097/QAI.0000000000003091. J Acquir Immune Defic Syndr. 2022. PMID: 36084200 Clinical Trial.
Self-initiated continuation of and adherence to HIV pre-exposure prophylaxis (PrEP) after PrEP demonstration project roll-off in men who have sex with men: associations with risky decision making, impulsivity/disinhibition, and sensation seeking.
Hoenigl M, Morgan E, Franklin D, Anderson PL, Pasipanodya E, Dawson M, Hanashiro M, Ellorin EE, Blumenthal J, Heaton R, Moore DJ, Morris SR; California Collaborative Treatment Group (CCTG) 601 Team. Hoenigl M, et al. Among authors: blumenthal j. J Neurovirol. 2019 Jun;25(3):324-330. doi: 10.1007/s13365-018-0716-3. Epub 2019 Jan 7. J Neurovirol. 2019. PMID: 30617849 Free PMC article. Clinical Trial.
Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study.
Moore DJ, Jain S, Dubé MP, Daar ES, Sun X, Young J, Corado K, Ellorin E, Milam J, Collins D, Blumenthal J, Best BM, Anderson P, Haubrich R, Morris SR. Moore DJ, et al. Among authors: blumenthal j. Clin Infect Dis. 2018 May 2;66(10):1566-1572. doi: 10.1093/cid/cix1055. Clin Infect Dis. 2018. PMID: 29228144 Free PMC article. Clinical Trial.
726 results